This is my understanding of your query:

    You are looking to use computational methods to propose new derivatives of existing synthetic hits.
    The goal is to enhance the activity of these compounds against tuberculosis.
    You also want to ensure that the new derivatives maintain good pharmacokinetic properties.
    You are seeking a computational approach to achieve this.

For your query, I have selected the following models:

Model: eos9ivc

URL: https://github.com/ersilia-os/eos9ivc

Title: Antituberculosis Activity Prediction

Explanation:

Based on the context , I would suggest using the " Comput ational Methods " section to guide your approach . Specifically , you can utilize :

    ** M olecular docking **: to predict the binding affinity of new derivatives to the target protein , such as the My cob acter ium tuberculosis enzyme .
    ** Quant um mechanics **: to optimize the molecular structure of the derivatives and predict their pharmac okin etic properties .
    ** Machine learning **: to identify patterns in the structure - activity relationship ( S AR ) of the synthetic hits and propose new derivatives with enhanced activity .

These computational methods can help you propose new derivatives that are likely to be effective against tuberculosis while maintaining good pharmac okin etics .

Model: eos24jm

URL: https://github.com/ersilia-os/eos24jm

Title: Qcrb Inhibition (M. Tuberculosis)

Explanation:

Based on the context , you can use computational methods to propose new derivatives of synthetic hits that enhance activity against tuberculosis while maintaining good pharmac okin etics by :

1 . ** Ret r aining the SVM model **: Use the same molecular features and E CF P 6 fingerprints to re train the SVM model with the new synthetic hits . 2 . ** M olecular editing **: Util ize molecular editing tools , such as RD Kit or Py bel , to modify the molecular structure of the synthetic hits while maintaining their core pharmac oph ore . 3 . ** Virtual screening **: Perform virtual screening of large compound libraries against the re trained SVM model to identify new derivatives with enhanced activity against tuberculosis . 4 . ** Ph armac okin etic prediction **: Use computational tools , such as AD ME -To x or pk CS M , to predict the pharmac okin etic properties of the new derivatives and identify those with good absorption , distribution , metabolism , and ex cretion ( AD ME ) profiles . 5 . ** In sil ico optimization **: Employ in sil ico optimization techniques , such as genetic algorithm or simulated anne aling , to iter atively modify the molecular structure of the new derivatives to enhance their activity and pharmac okin etics .

By following these steps , you can comput ationally propose new derivatives of synthetic hits that enhance activity against tuberculosis while maintaining good pharmac okin etics .

Model: eos8d8a

URL: https://github.com/ersilia-os/eos8d8a

Title: Membrane Permeability In Mycobacterium Tuberculosis

Explanation:

Based on the context , you can use My c Perm Check , a tool for predicting my cob acterial perme ability , to propose new derivatives of synthetic hits that enhance activity against tuberculosis while maintaining good pharmac okin etics . Here 's a concise step -by -step approach :

1 . ** Ident ify synthetic hits **: Use existing databases or literature to identify synthetic compounds that have shown activity against tuberculosis . 2 . ** Predict perme ability **: Use My c Perm Check to predict the perme ability of these synthetic hits across the my cob acterial cell wall . 3 . ** An alyze results **: Evaluate the predicted perme ability probabilities to identify compounds with high perme ability . 4 . ** Design new derivatives **: Use computational methods , such as molecular modeling and virtual screening , to design new derivatives of the identified synthetic hits . 5 . ** Predict pharmac okin etics **: Use computational tools , such as AD ME ( Abs orption , Distribution , Met abol ism , and Ex cretion ) prediction software , to evaluate the pharmac okin etic properties of the new derivatives . 6 . ** Opt imize and refine **: Ref ine the new derivatives based on the predicted pharmac okin etics and perme ability , and re -e valuate their activity against tuberculosis .

By following this approach , you can propose new derivatives of synthetic hits that enhance activity against tuberculosis while maintaining good pharmac okin etics , ultimately contributing to the development of more effective treatments for this disease .

Model: eos7kpb

URL: https://github.com/ersilia-os/eos7kpb

Title: H3D Virtual Screening Cascade Light

Explanation:

Based on the context , you can use the Z aira Chem AI / ML tool to propose new derivatives of synthetic hits that enhance activity against tuberculosis while maintaining good pharmac okin etics . Here 's a concise step -by -step guide :

1 . ** Input your hit compound **: Provide the molecular structure of the synthetic hit compound to Z aira Chem . 2 . ** Run QS AR /Q SP R models **: Z aira Chem will employ AI / ML techniques to predict the activity and pharmac okin etic properties of the hit compound . 3 . ** An alyze results **: Review the predicted activity and pharmac okin etic properties to identify potential areas for improvement . 4 . ** Prop ose modifications **: Use Z aira Chem 's Auto ML algorithms to suggest modifications to the hit compound , such as changes to functional groups or molecular structure . 5 . ** Evaluate new compounds **: Run the modified compounds through Z aira Chem 's QS AR /Q SP R models to predict their activity and pharmac okin etic properties . 6 . ** Select and prioritize **: Choose the most promising new compounds for synthesis and experimental validation .

By following these steps , you can leverage Z aira Chem 's computational methods to propose new derivatives of synthetic hits that enhance activity against tuberculosis while maintaining good pharmac okin etics .

Use the following recipe to run the identified models on your data. The following instructions assume that your dataset is stored in a file called 'input.csv'.

This file should contain a column called smiles with the SMILES strings of the molecules in your dataset.

ersilia fetch eos9ivc
ersilia serve eos9ivc
ersilia run -i input.csv -o output_eos9ivc.csv

ersilia fetch eos24jm
ersilia serve eos24jm
ersilia run -i input.csv -o output_eos24jm.csv

ersilia fetch eos8d8a
ersilia serve eos8d8a
ersilia run -i input.csv -o output_eos8d8a.csv

ersilia fetch eos7kpb
ersilia serve eos7kpb
ersilia run -i input.csv -o output_eos7kpb.csv
